ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

Bonadonna, Fisher Share %50,000 Bristol-Myers Award

April 23, 1993

Clearinghouse Finds Three Chemicals Pose Risk Of Cncer to Humans; 38 More Will Go On Test

August 5, 1977

Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements

December 11, 1981

In Brief: NCI Ponders How Extra $40 Million Will Be Spent, Will Submit Plans to NCAB At Upcoming Meeting

January 14, 1983

Aging Committee Hears Prospects For Immunotherapy

July 27, 1979